Case Report
Accepted on 31 Oct 2025
Late-Onset Severe Neutropenia in Patients with Relapsing Remitting Multiple Sclerosis Treated with Ocrelizumab: Case Report and Literature Review
in Neuropharmacology
Frontiers in Neuroscience
Type at least 3 characters
1,055 articles
Review
Accepted on 21 Oct 2025
The multi-pathway treatment of flavonoids as natural compounds in neurological diseases: achievements, limitations, and prospects
in Neuropharmacology
Frontiers in Neuroscience
- 348 views
Review
Published on 17 Oct 2025
Nicotine and neuronal nicotinic acetylcholine receptors: unraveling the mechanisms of nicotine addiction
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2025.1670883
- 1,651 views
Original Research
Accepted on 14 Oct 2025
Neuroimaging and Molecular Mechanism of Action of Cang-ai Volatile Oil in the Treatment of Vascular Cognitive Impairment
in Neuropharmacology
Frontiers in Neuroscience
- 166 views
Original Research
Accepted on 13 Oct 2025
A Study on Neurotransmitter Levels in Rats with Tic Disorder Treated with Aripiprazole
in Neuropharmacology
Frontiers in Neuroscience
- 185 views
Brief Research Report
Published on 08 Oct 2025
Proof of concept for high-dose Cannabidiol pretreatment to antagonize opioid induced persistent apnea in mice
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2025.1654787
- 3,861 views
Retraction
Published on 03 Oct 2025
Retraction: Olanzapine-induced activation of hypothalamic astrocytes and toll-like receptor-4 signaling via endoplasmic reticulum stress were related to olanzapine-induced weight gain
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2025.1713245
- 1,062 views
Brief Research Report
Published on 02 Oct 2025
Human in vivo assessment of ketamine binding of the serotonin transporter—follow up at a higher dose
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2025.1651016
- 2,387 views
Review
Published on 19 Sep 2025
Study on the protective effects and mechanisms of eleutherococcus senticosus on korsakoff syndrome
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2025.1670516
- 2,824 views
Original Research
Published on 04 Sep 2025
Ineffectiveness of pioglitazone in cognitive impairment induced by cyclophosphamide, methotrexate, and fluorouracil via oxidative stress and neuroinflammation
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2025.1648041
- 2,845 views
Correction
Accepted on 28 Aug 2025
Correction: Tetrahydrocannabinol and dopamine D1 receptor
in Neuropharmacology
Frontiers in Neuroscience
- 1,822 views
Original Research
Published on 18 Aug 2025
Effects of all-trans retinoic acid on glutamate receptor expression and dendritic spine density in the hypothalamus of rats
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2025.1616330
- 1,747 views
Review
Published on 15 Aug 2025
Deciphering sevoflurane-induced neurotoxicity: from isolated targets to intricate regulatory networks
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2025.1646246
- 2,625 views
Review
Published on 13 Aug 2025
Exploring novel roles of lipid droplets and lipid metabolism in regulating inflammation and blood–brain barrier function in neurological diseases
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2025.1603292
- 3,582 views
Original Research
Published on 25 Jul 2025
Endocannabinoid-mediated regulation of depression in the ovBNST
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2025.1629351
- 1,876 views
Original Research
Published on 23 Jul 2025
Potential therapeutic effects of Ebixa, Ginkgo biloba, and selenium in a cadmium chloride-induced Alzheimer’s disease manifestations in rats
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2025.1634601
- 2,308 views